27 Article(s)Download |
PMID | Title | Pub. Year | #Total Relationships |
1 | 33787344 | Gab1 in livers with persistent hepatocyte apoptosis has an antiapoptotic effect and reduces chronic liver injury, fibrosis, and tumorigenesis. | 2021 Jun 1 | 2 |
2 | 34659562 | Metformin exerts a synergistic effect with venetoclax by downregulating Mcl-1 protein in acute myeloid leukemia. | 2021 | 1 |
3 | 30017199 | ABT-199-mediated inhibition of Bcl-2 as a potential therapeutic strategy for nasopharyngeal carcinoma. | 2018 Sep 10 | 1 |
4 | 28319809 | ABT-737 Synergizes with Cisplatin Bypassing Aberration of Apoptotic Pathway in Non-small Cell Lung Cancer. | 2017 Apr | 1 |
5 | 28533436 | Metformin Synergizes with BCL-XL/BCL-2 Inhibitor ABT-263 to Induce Apoptosis Specifically in p53-Defective Cancer Cells. | 2017 Sep | 2 |
6 | 29237758 | Targeted apoptosis of myofibroblasts with the BH3 mimetic ABT-263 reverses established fibrosis. | 2017 Dec 13 | 1 |
7 | 27560714 | MCL-1 is required throughout B-cell development and its loss sensitizes specific B-cell subsets to inhibition of BCL-2 or BCL-XL. | 2016 Aug 25 | 2 |
8 | 25862283 | Bcl-xL stimulates Bax relocation to mitochondria and primes cells to ABT-737. | 2015 Jul | 3 |
9 | 25880088 | BCL-2 is dispensable for thrombopoiesis and platelet survival. | 2015 Apr 16 | 1 |
10 | 26038117 | Activation of the Mitochondrial Apoptotic Pathway Produces Reactive Oxygen Species and Oxidative Damage in Hepatocytes That Contribute to Liver Tumorigenesis. | 2015 Aug | 1 |
11 | 24632563 | Platelet production proceeds independently of the intrinsic and extrinsic apoptosis pathways. | 2014 Mar 17 | 1 |
12 | 25023286 | Bcl-xL protein protects from C/EBP homologous protein (CHOP)-dependent apoptosis during plasma cell differentiation. | 2014 Aug 22 | 1 |
13 | 25208888 | A Bim-targeting strategy overcomes adaptive bortezomib resistance in myeloma through a novel link between autophagy and apoptosis. | 2014 Oct 23 | 1 |
14 | 25368242 | BH3 mimetics inhibit growth of chondrosarcoma--a novel targeted-therapy for candidate models. | 2014 Nov | 2 |
15 | 22814621 | Prophylactic treatment with the BH3 mimetic ABT-737 impedes Myc-driven lymphomagenesis in mice. | 2013 Jan | 1 |
16 | 23341542 | ABT-199, a new Bcl-2-specific BH3 mimetic, has in vivo efficacy against aggressive Myc-driven mouse lymphomas without provoking thrombocytopenia. | 2013 Mar 21 | 2 |
17 | 23986435 | The Bcl-2 homology domain 3 (BH3)-only proteins Bim and bid are functionally active and restrained by anti-apoptotic Bcl-2 family proteins in healthy liver. | 2013 Oct 18 | 1 |
18 | 24227720 | Tonic activation of Bax primes neural progenitors for rapid apoptosis through a mechanism preserved in medulloblastoma. | 2013 Nov 13 | 1 |
19 | 21768359 | Sensitization of BCL-2-expressing breast tumors to chemotherapy by the BH3 mimetic ABT-737. | 2012 Feb 21 | 1 |
20 | 21997189 | Pharmacological blockade of Bcl-2, Bcl-x(L) and Bcl-w by the BH3 mimetic ABT-737 has only minor impact on tumour development in p53-deficient mice. | 2012 Apr | 1 |
21 | 22510411 | A defect in cell death of macrophages is a conserved feature of nonobese diabetic mouse. | 2012 Apr 27 | 1 |
22 | 22790873 | Mcl-1 and Bcl-xL regulate Bak/Bax-dependent apoptosis of the megakaryocytic lineage at multistages. | 2012 Nov | 1 |
23 | 21719460 | Evaluation of the Bcl-2 family antagonist ABT-737 in collagen-induced arthritis. | 2011 Oct | 1 |
24 | 20535152 | Effective targeting of STAT5-mediated survival in myeloproliferative neoplasms using ABT-737 combined with rapamycin. | 2010 Aug | 1 |
25 | 18841882 | Discovery of an orally bioavailable small molecule inhibitor of prosurvival B-cell lymphoma 2 proteins. | 2008 Nov 13 | 1 |
26 | 19004807 | In vivo efficacy of the Bcl-2 antagonist ABT-737 against aggressive Myc-driven lymphomas. | 2008 Nov 18 | 1 |
27 | 17508927 | Small molecule inhibition of the Bcl-X(L)-BH3 protein-protein interaction: proof-of-concept of an in vivo chemopotentiator ABT-737. | 2007 | 1 |